Scientists Find New Way to Stop Deadly Breast Cancer

Women facing one of the deadliest forms of breast cancer may soon have a powerful new weapon that spares them the harsh side effects of chemotherapy.

Scientists at the Medical University of South Carolina have developed a one-two punch strategy that stops triple-negative breast cancer in its tracks. The approach works by first weakening cancer cells, then blocking the backup system they desperately try to use to survive.

Triple-negative breast cancer earns its frightening reputation because it lacks the three common targets doctors use to treat other breast cancers. That leaves chemotherapy as the main option, which comes with brutal side effects and often fails as tumors develop resistance.

The research team, led by Dr. Ozgur Sahin, discovered that a protein called LOX does much more than previously thought. While scientists knew LOX helped cancer spread by stiffening surrounding tissue, they found it also works inside cancer cells to keep them alive.

When researchers blocked LOX, cancer cells struggled to produce energy and cope with stress. But the cells fought back by relying more heavily on a backup defense system controlled by a protein called DHODH.

That adaptation became the cancer's downfall. The scientists realized they could deliver a second hit by blocking DHODH, overwhelming the cells completely.

The team tested their strategy in multiple laboratory models, including tumors from patients whose cancers had already resisted chemotherapy. They paired an experimental drug blocking LOX with a second drug targeting DHODH.

The results showed significant tumor growth reduction across all models. The combination triggered ferroptosis, a type of cell death where toxic molecules build up until cancer cells collapse.

Why This Inspires

This discovery represents more than just another potential treatment. It offers hope to women facing a cancer subtype with notoriously few options and high recurrence rates.

The approach works without chemotherapy, potentially sparing patients from debilitating side effects like nausea, hair loss, and immune system damage. For women who watch their tumors return despite brutal treatment rounds, this research opens a different path forward.

The strategy also demonstrates a smarter way to fight cancer by understanding how tumors adapt and survive. Rather than hitting cancer cells with a sledgehammer, this method strategically removes their defenses one by one.

The findings, published in Cell Reports Medicine in August 2026, move the field closer to targeted therapies that work with precision instead of brute force.

A future where triple-negative breast cancer loses its deadly edge is coming into focus.